Abstract
Spinal cord injury (SCI) represents an urgent unmet need for clinical reparative therapy due to its largely irreversible and devastating effects on patients, and the tremendous socioeconomic burden to the community. While different approaches are being explored, therapy to restore the lost function remains unavailable. Olfactory ensheathing cell (OEC) transplantation is a promising approach in terms of feasibility, safety, and limited efficacy; however, high variability in reported clinical outcomes prevent its translation despite several clinical trials. The aims of this position paper are to present an in-depth analysis of previous OEC transplantation-based clinical trials, identify existing challenges and gaps, and finally propose strategies to improve standardization of OEC therapies. We have reviewed the study design and protocols of clinical trials using OEC transplantation for SCI repair to investigate how and why the outcomes show variability. With this knowledge and our experience as a team of biologists and clinicians with active experience in the field of OEC research, we provide recommendations regarding cell source, cell purity and characterisation, transplantation dosage and format, and rehabilitation. Ultimately, this position paper is intended to serve as a roadmap to design an effective clinical trial with OEC transplantation-based therapy for SCI repair.
Funder
Motor Accident Insurance Commission
Clem Jones Foundation
Perry Cross Spinal Research Foundation
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference65 articles.
1. Spinal Cure Australia (2020). Spinal Cord Injury in Australia: The Case for Investing in New Treatments, Spinal Cure Australia.
2. Neurological and functional status 1 year after acute spinal cord injury: Estimates of functional recovery in National Acute Spinal Cord Injury Study II from results modeled in National Acute Spinal Cord Injury Study III;Bracken;J. Neurosurg.,2002
3. From basics to clinical: A comprehensive review on spinal cord injury;Silva;Prog. Neurobiol.,2014
4. Neuroimmunological therapies for treating spinal cord injury: Evidence and future perspectives;Chio;Exp. Neurol.,2021
5. Survival and Integration of Transplanted Olfactory Ensheathing Cells are Crucial for Spinal Cord Injury Repair: Insights from the Last 10 Years of Animal Model Studies;Reshamwala;Cell Transplant.,2019
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献